6533b857fe1ef96bd12b4628
RESEARCH PRODUCT
Patterns of care and cost profiles of women with breast cancer in Italy: EPICOST study based on real world data
Susanna BuscoDiego SerrainoSilvia IacovacciTania LopezCatia AngioliniRosanna CusimanoGiulia CapodaglioAlessandro BarchielliAnna GigliMassimo RuggeSilvia FrancisciFortunato BianconiStefano GuzzinatiFabrizio StracciAndrea TavillaWalter MazzuccoAntonio RussoMario FuscoManuel ZorziDaniela PierannunzioSandra Mallonesubject
medicine.medical_specialtyReal world dataTotal costEconomics Econometrics and Finance (miscellaneous)PopulationHealth care utilizationAdministrative dataBreast NeoplasmsSettore MED/42 - Igiene Generale E Applicata03 medical and health sciencesInsurance Claim Review0302 clinical medicineBreast cancerBreast cancerEnvironmental healthHealth careCost analysiCost analysisMedicineHumans030212 general & internal medicineRegistrieseducationRetrospective Studieseducation.field_of_studyHealth economicsbusiness.industry030503 health policy & servicesHealth PolicyPublic healthmedicine.diseaseHospitalizationCross-Sectional StudiesItalyCost driverCohortFemaleHealth Expenditures0305 other medical sciencebusinessDelivery of Health Caredescription
Objectives To estimate total direct health care costs associated to diagnosis and treatment of women with breast cancer in Italy, and to investigate their distribution by service type according to the disease pathway and patient characteristics. Methods Data on patients provided by population-based Cancer Registries are linked at individual level with data on health-care services and corresponding claims from administrative databases. A combination of cross-sectional approach and a threephase of care decomposition model with initial, continuing and final phases-of-care defined according to time occurred since diagnosis and disease outcome is adopted. Direct estimation of cancer-related costs is obtained. Results Study cohort included 49,272 patients, 15.2% were in the initial phase absorbing 42% of resources, 79.7% in the continuing phase absorbing 44% of resources and 5.1% in the final phase absorbing 14% of resources. Hospitalization was the most important cost driver, accounting for over 55% of the total costs. Conclusions This paper represents the first attempt in Italy to estimate the economic burden of cancer at population level taking into account the entire disease pathway and using multiple current health care databases. The evidence produced by the study can be used to better plan resources allocation. The model proposed is replicable to countries with individual health care information on services and claims.
year | journal | country | edition | language |
---|---|---|---|---|
2020-01-01 |